Drug Profile
TAC 401
Alternative Names: TAC401Latest Information Update: 30 Sep 2019
Price :
$50
*
At a glance
- Originator Taiho Pharmaceutical
- Class Anti-infectives
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 30 Sep 2019 Discontinued - Phase-II for Helicobacter infections in Japan (PO)